The safety and efficacy of topical 1% ALO 2145 (p-aminoclonidine hydrochloride) in normal volunteers
Abrams D.A., Robin A.L., Pollack I.P., et al. The safety and efficacy of topical 1% ALO 2145 (p-aminoclonidine hydrochloride) in normal volunteers. Arch Ophthalmol 105 (1987) 1205-1207
Effect of topical apraclonidine on flow properties of central retinal and ophthalmic arteries
Celiker U.O., Çelebi S., Çeliker H., and Çelebi H. Effect of topical apraclonidine on flow properties of central retinal and ophthalmic arteries. Acta Ophthalmol Scand 74 (1996) 151-154
A comparative study on the effects of apraclonidine and timolol on the ophthalmic blood flow velocity waveforms
Oruç S., and Sener E.C. A comparative study on the effects of apraclonidine and timolol on the ophthalmic blood flow velocity waveforms. Int Ophthalmol 23 (1999) 69-73
The one-month effects of topical betaxolol, dorzolamide and apraclonidine on ocular blood flow velocities in patients with newly diagnosed primary open-angle glaucoma
Avunduk A.M., Sari A., Akyol N., et al. The one-month effects of topical betaxolol, dorzolamide and apraclonidine on ocular blood flow velocities in patients with newly diagnosed primary open-angle glaucoma. Ophthalmologica 215 (2001) 361-365
Vasoactive drug effects on the uveal vasculature of the rabbit; a corrosion casting study. ARVO abstract 14
Fahrenbach W.H., Bacon D.R., and Van Buskirk E.M. Vasoactive drug effects on the uveal vasculature of the rabbit; a corrosion casting study. ARVO abstract 14. Invest Ophthalmol Vis Sci 30 Suppl (1989) 100
Ocular perfusion pressure and visual field indice modifications induced by α-agonist compound (clonidine 0.125%, apraclonidine 1.0% and brimonidine 0.2%) topical administration; an acute study on primary open-angle glaucoma patients
Costagliola C., Parmeggiani F., Ciancaglini M., et al. Ocular perfusion pressure and visual field indice modifications induced by α-agonist compound (clonidine 0.125%, apraclonidine 1.0% and brimonidine 0.2%) topical administration; an acute study on primary open-angle glaucoma patients. Ophthalmologica 217 (2003) 39-44